Found: 75
Select item for more details and to access through your institution.
Myocardial Oxygen Extraction Fraction Measured Using Bolus Inhalation of <sup>15</sup>O-Oxygen Gas and Dynamic PET.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 1, p. 60, doi. 10.2967/jnumed.110.080408
- By:
- Publication type:
- Article
Open‐label study with the monoamine stabilizer (‐)‐OSU6162 in myalgic encephalomyelitis/chronic fatigue syndrome.
- Published in:
- Brain & Behavior, 2021, v. 11, n. 4, p. 1, doi. 10.1002/brb3.2040
- By:
- Publication type:
- Article
Synthesis and preclinical evaluation of [<sup>11</sup>C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor.
- Published in:
- EJNMMI Research, 2024, v. 14, p. 1, doi. 10.1186/s13550-024-01078-6
- By:
- Publication type:
- Article
The Dopamine Stabilizer (−)-OSU6162 Occupies a Subpopulation of Striatal Dopamine D2/D3 Receptors: An [<sup>11</sup>C]Raclopride PET Study in Healthy Human Subjects.
- Published in:
- Neuropsychopharmacology, 2015, v. 40, n. 2, p. 472, doi. 10.1038/npp.2014.195
- By:
- Publication type:
- Article
Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum.
- Published in:
- Neuropsychopharmacology, 2009, v. 34, n. 3, p. 759, doi. 10.1038/npp.2008.138
- By:
- Publication type:
- Article
Regional tau pathology is associated with loss of synapses and reduced synaptic activity: A combined [<sup>18</sup>F]flortaucipir, [<sup>11</sup>C]UCB‐J and magnetoencephalography study: Neuroimaging: Imaging the human synapse in AD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045806
- By:
- Publication type:
- Article
P3‐438: PARAMETRIC IMAGING OF [<sup>18</sup>F]FLORBETAPIR: A TEST‐RETEST STUDY IN HEALTHY SUBJECTS AND PATIENTS WITH ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1281, doi. 10.1016/j.jalz.2018.06.1801
- By:
- Publication type:
- Article
PARAMETRIC IMAGING OF TAU LOAD IN ALZHEIMER’S PATIENTS AND CONTROLS USING FLORTAUCIPIR.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1364, doi. 10.1016/j.jalz.2017.06.2103
- By:
- Publication type:
- Article
PARAMETRIC IMAGING OF TAU LOAD IN ALZHEIMER’S PATIENTS AND CONTROLS USING FLORTAUCIPIR.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P150, doi. 10.1016/j.jalz.2017.06.2582
- By:
- Publication type:
- Article
QUANTIFICATION OF TAU LOAD USING [18F]AV-1451 AND PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1109, doi. 10.1016/j.jalz.2016.06.2307
- By:
- Publication type:
- Article
QUANTIFICATION OF TAU LOAD USING [18F]AV-1451 AND PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P141, doi. 10.1016/j.jalz.2016.06.227
- By:
- Publication type:
- Article
Blood-brain barrier p-glycoprotein function in Alzheimer's disease
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Biodistribution of <sup>18</sup>F-FES in patients with metastatic ER+ breast cancer undergoing treatment with Rintodestrant (G1T48), a novel selective estrogen receptor degrader.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262500
- By:
- Publication type:
- Article
Biodistribution of <sup>18</sup>F-FES in patients with metastatic ER+ breast cancer undergoing treatment with Rintodestrant (G1T48), a novel selective estrogen receptor degrader.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262500
- By:
- Publication type:
- Article
Biodistribution of <sup>18</sup>F-FES in patients with metastatic ER+ breast cancer undergoing treatment with Rintodestrant (G1T48), a novel selective estrogen receptor degrader.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262500
- By:
- Publication type:
- Article
<sup>11</sup>C-sorafenib and <sup>15</sup>O-H<sub>2</sub>O PET for early evaluation of sorafenib therapy.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.251611
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [<sup>18</sup>F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
<sup>11</sup>C-sorafenib and <sup>15</sup>O-H<sub>2</sub>O PET for early evaluation of sorafenib therapy.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.251611
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [ <sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [<sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [<sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [<sup>18</sup>F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [ 18F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [<sup>18</sup>F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [<sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Simplified Methods for Quantification of <sup>18</sup>F‐DCFPyL Uptake in Patients with Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.227520
- By:
- Publication type:
- Article
Assessment of simplified methods for quantification of 18F-FDHT uptake in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.220111
- By:
- Publication type:
- Article
Assessment of Simplified Methods for Quantification of <sup>18</sup>F-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 9, p. 1221, doi. 10.2967/jnumed.118.220111
- By:
- Publication type:
- Article
Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 10, p. 1516, doi. 10.2967/jnumed.117.206490
- By:
- Publication type:
- Article
Human Dosimetry of the N-Methyl-d-Aspartate Receptor Ligand <sup>11</sup>C-GMOM.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 8, p. 1330, doi. 10.2967/jnumed.116.188250
- By:
- Publication type:
- Article
Parametric Binding Images of the TSPO Ligand <sup>18</sup>F-DPA-714.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 10, p. 1543, doi. 10.2967/jnumed.116.173013
- By:
- Publication type:
- Article
Noninvasive Quantification of Myocardial <sup>11</sup>C-Meta-Hydroxyephedrine Kinetics.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 9, p. 1376, doi. 10.2967/jnumed.115.167437
- By:
- Publication type:
- Article
Quantitative and Simplified Analysis of <sup>11</sup>C-Erlotinib Studies.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 6, p. 861, doi. 10.2967/jnumed.115.165225
- By:
- Publication type:
- Article
Quantification of <sup>11</sup>C-Laniquidar Kinetics in the Brain.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 11, p. 1730, doi. 10.2967/jnumed.115.157586
- By:
- Publication type:
- Article
Use of a Single <sup>11</sup>C-Meta-Hydroxyephedrine Scan for Assessing Flow-Innervation Mismatches in Patients with Ischemic Cardiomyopathy.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 11, p. 1706, doi. 10.2967/jnumed.115.154377
- By:
- Publication type:
- Article
Quantification of <sup>18</sup>F-Fluorocholine Kinetics in Patients with Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 3, p. 365, doi. 10.2967/jnumed.114.148007
- By:
- Publication type:
- Article
Parametric Methods for Quantification of <sup>18</sup>F-FAZA Kinetics in Non-Small Cell Lung Cancer Patients.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 11, p. 1772, doi. 10.2967/jnumed.114.141846
- By:
- Publication type:
- Article
Assessment of Simplified Methods to Measure <sup>18</sup>F-FLT Uptake Changes in EGFR-Mutated Non-Small Cell Lung Cancer Patients Undergoing EGFR Tyrosine Kinase Inhibitor Treatment.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 9, p. 1417, doi. 10.2967/jnumed.114.140913
- By:
- Publication type:
- Article
Radiation Dose of the P-Glycoprotein Tracer <sup>11</sup>C-Laniquidar.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 12, p. 2101, doi. 10.2967/jnumed.113.120857
- By:
- Publication type:
- Article
Relationship between Biodistribution and Tracer Kinetics of 11 C-Erlotinib, 18 F-Afatinib and 11 C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis in Advanced Stage Non-Small Cell Lung Cancer Patients.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 4, p. 883, doi. 10.3390/diagnostics12040883
- By:
- Publication type:
- Article
Kinetics and 28-day test–retest repeatability and reproducibility of [ 11 C]UCB-J PET brain imaging.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2021, v. 41, n. 6, p. 1338, doi. 10.1177/0271678X20964248
- By:
- Publication type:
- Article
Repeatability of parametric methods for [ 18 F]florbetapir imaging in Alzheimer's disease and healthy controls: A test–retest study.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2021, v. 41, n. 3, p. 569, doi. 10.1177/0271678X20915403
- By:
- Publication type:
- Article
Parametric methods for [ 18 F]flortaucipir PET.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2020, v. 40, n. 2, p. 365, doi. 10.1177/0271678X18820765
- By:
- Publication type:
- Article
Quantification of [ 18 F]florbetapir: A test–retest tracer kinetic modelling study.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2019, v. 39, n. 11, p. 2172, doi. 10.1177/0271678X18783628
- By:
- Publication type:
- Article
Altered GABA<sub>A</sub> receptor density and unaltered blood-brain barrier [<sup>11</sup>C]flumazenil transport in drug-resistant epilepsy patients with mesial temporal sclerosis.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2017, v. 37, n. 1, p. 91, doi. 10.1177/0271678X15618219
- By:
- Publication type:
- Article
Quantification of the novel N-methyl-D-aspartate receptor ligand [<sup>11</sup>C]GMOM in man.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2016, v. 36, n. 6, p. 1111, doi. 10.1177/0271678X15608391
- By:
- Publication type:
- Article
Synthesis of [3- N-<sup>11</sup>C-methyl]temozolomide via in situ activation of 3- N-hydroxymethyl temozolomide and alkylation with [<sup>11</sup>C]methyl iodide.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2015, v. 58, n. 3, p. 122, doi. 10.1002/jlcr.3251
- By:
- Publication type:
- Article
Synthesis and initial preclinical evaluation of the P2X<sub>7</sub> receptor antagonist [<sup>11</sup>C]A-740003 as a novel tracer of neuroinflammation.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2014, v. 57, n. 8, p. 509, doi. 10.1002/jlcr.3206
- By:
- Publication type:
- Article